May 11, 2017May 12, 2017May 13, 2017

May 13, 2017

TIME MEETING HALL A MEET THE EXPERT HALL 
08:30 – 10:00 FOLLICULAR LYMPHOMA

Scientific Chairs: Massimo Federico (Università degli Studi di Modena e Reggio Emilia, Modena, Italy), Burhan Ferhanoğlu (Koç University, Istanbul, Turkey)

  • First Line Therapy for Follicular Lymphoma: Elif Birtaş Ateşoğlu (Kocaeli University, Izmit, Turkey)
  • Are We Ready for a Chemofree Approach for Treating Patients with Advanced Follicular Lymphoma?: Armando Lopez Guillermo (Hospital Clinic of Barcelona, Barcelona, Spain)
  • Maintenance Therapy: All Fit in One?:Massimo Federico (Università degli Studi di Modena e Reggio Emilia, Modena, Italy)
10:00 – 10:30 COFFEE BREAK
10:30 – 11:30 SATELLITE SYMPOSIUM

Scientific Chair: Yıldız Aydın (İstanbul University, İstanbul, Turkey)NEW HOPE for RRMM Patients: FOCUS on Efficacy & Safety of IMNOVID: Meral Beksaç (Ankara University, Ankara, Turkey)
11:30 – 11:45 BREAK
11:45 – 13:15 CHRONIC MYELOID LEUKEMIA

Scientific Chairs:  Hanan Hamed (Ain Shams University, Cairo, Egypt), Teoman Soysal (Istanbul University, Istanbul, Turkey) 

  • WHO 2016 Diagnostic Criteria of CML; What is Old, What is New?:  Hanan Hamed (Ain Shams University, Cairo, Egypt)
  • Current Molecular Monitoring of CML: Akif Selim Yavuz (Istanbul University, Istanbul, Turkey)
  • Current Clinical Management of CML: İbrahim C. Haznedaroğlu (Hacettepe University, Ankara, Turkey)
13:15 – 14:30 LUNCH POSTER DISCUSSION
14:30 – 16:30 CHRONIC LYMPHOCYTIC LEUKEMIA / AGGRESSIVE LYMPHOMAS

Scientific Chairs: Oliver Karanfilski (University Clinic for Hematology, Skopje, Macedonia), Önder Arslan (Ankara University, Ankara, Turkey)

  • Prognostic Factors in Newly Diagnosed CLL: Oliver Karanfilski (University Clinic for Hematology, Skopje, Macedonia)
  • First-Line Therapy for CLL as of 2017: Fatih Demirkan (Dokuz Eylül University, Izmir, Turkey)
  • Relapse/Refractory CLL Treatment: Ioannis Kotsianidis (University Hospital of Alexandroupolis, Alexandroupoli, Greece)
  • The Role of Allogeneic Stem Cell Transplantation in the Treatment of Aggressive Lymphomas: Anna Sureda (Hospital Duran i Reynals, Barcelona, Spain)